info@news-matic.com

details

T-DXd Plus Pertuzumab Sets New Treatment and Research Standards in HER2+ Breast Cancer

Milana V. Dolezal, MD, MSci, notes how the CLEOPATRA trial paved the way for further breast cancer research and highlighted data from DESTINY-Breast09.

ADVERTISEMENT

Cookie Consent + Tracking